Suptavumab: A Deep Dive into the REGN2222 Monoclonal Antibody REGN2222 is a therapeutic antibody created to selectively inhibit IL18, a key cytokine implicated in severe respiratory syndrome syndrome https://haarisohwd279091.blog-gold.com/profile